G. van Setten Et Al. , "The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial.," Journal of clinical medicine , vol.9, no.11, 2020
van Setten, G. Et Al. 2020. The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial.. Journal of clinical medicine , vol.9, no.11 .
van Setten, G., Baudouin, C., Horwath-Winter, J., Boehringer, D., Stachs, O., Toker, E., ... Al-Zaaidi, S.(2020). The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial.. Journal of clinical medicine , vol.9, no.11.
van Setten, Gysbert-Botho Et Al. "The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial.," Journal of clinical medicine , vol.9, no.11, 2020
van Setten, Gysbert-Botho v. Et Al. "The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial.." Journal of clinical medicine , vol.9, no.11, 2020
van Setten, G. Et Al. (2020) . "The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial.." Journal of clinical medicine , vol.9, no.11.
@article{article, author={Gysbert-Botho van Setten Et Al. }, title={The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial.}, journal={Journal of clinical medicine}, year=2020}